Eurofins to invest Rs.1,000 cr in Telangana: KTR signs deal at WEF

The cutting-edge laboratories cover an area of more than 90,000 square feet

Eurofins to invest Rs.1,000 cr in Telangana: KTR signs deal at WEF

HYDERABAD: Eurofins Scientific (EUFI.PA), a global leader in food, environment, pharmaceutical, and cosmetic product testing as well as a global scientific leader in bioanalytical testing, announced on Wednesday the acquisition of assets to establish a fully-equipped, state-of-the-art laboratory campus in Genome Valley, Hyderabad.

The acquisition includes a facility capable of assisting large global and Indian pharmaceutical clients as well as small biotech companies with synthetic organic chemistry, analytical R&D, bioanalytical services (for both large and small molecules), in-vivo pharmacology, safety toxicology, and formulation R&D. The cutting-edge laboratories cover an area of more than 90,000 square feet.

The announcement was made after Minister KT Rama Rao’s meeting with Eurofins management at the World Economic Forum in Davos. The meeting also included Jayesh Ranjan IAS, Principal Secretary, Industries and Commerce Department, and Shakthi M Nagappan, Director Life sciences, Government of Telangana.

The Eurofins network now has a substantial campus in Hyderabad, which complements its current operations in India with extra capacity in discovery chemistry, analytical chemistry, and bioanalytical services, thanks to this investment through its subsidiary Eurofins Advinus. The investment would also enable Eurofins Advinus to expand its service offering to include formulation development, in-vitro and in-vivo biology capabilities, beginning in early 2023.

Dr Gilles Martin, Eurofins CEO said, “Eurofins is committed to long-term investments to grow our globally leading laboratory network. Given the importance of India in global pharmaceutical R&D value chains, we are very excited about our new Hyderabad campus so we can better serve this important centre for pharmaceutical development and innovation.”

Minister K.T. Rama Rao said, “I am delighted to announce the entry of Eurofins in Hyderabad and Genome Valley. I am extremely thrilled to note that the company has ambitious growth plans from this facility. With this investment, Eurofins joins an illustrious list of global companies in Genome Valley. The Telangana Government is committed to supporting Eurofins and their plans.”

Hyderabad: Epicenter of Drug Discovery

Hyderabad is regarded as the epicentre of drug discovery and development services in Asia, while Genome Valley is India’s first organised cluster for Life Sciences R&D and Clean Manufacturing activities, with world-class infrastructure facilities in the form of Industrial / Knowledge Parks, Special Economic Zones (SEZs), multi-tenanted dry and wet laboratories and incubation facilities. Genome Valley is home to more than 200 companies with a scientific workforce of about 15,000 professionals, working for industry leaders in global and Indian pharmaceuticals. This investment by Eurofins Advinus further reinforces the position of Hyderabad as a world class location for drug discovery.

Next Story

Similar Posts